A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery

References

• TacarOSriamornsakPDassCRDoxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systemsJ Pharm Pharmacol201365215717023278683
   PubMed Web of Science ®Google Scholar
• De BeerELBottoneAEVoestEEDoxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a reviewEur J Pharmacol2001415111111245845
   PubMed Web of Science ®Google Scholar
• DoroshowJHDoxorubicin-induced cardiac toxicityN Engl J Med1991324128438451997858
   PubMed Web of Science ®Google Scholar
• Granados-PrincipalSQuilesJLRamirez-TortosaCLSanchez-RoviraPRamirez-TortosaMCNew advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrientsFood Chem Toxicol20104861425143820385199
   PubMed Web of Science ®Google Scholar
• FojtuMGumulecJStracinaTReduction of doxorubicin-induced cardiotoxicity using nanocarriers: a reviewCurr Drug Metab201718323726328059036
   PubMed Web of Science ®Google Scholar
• Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliver Rev201264206212
   Web of Science ®Google Scholar
• MacKayJAChenMNMcDanielJRLiuWGSimnickAJChilkotiASelf-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injectionNat Mater200981299399919898461
   PubMed Web of Science ®Google Scholar
• ZouYFangYMengHSelf-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: a robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapyJ Control Release2016244Pt B32633527245309
   PubMedGoogle Scholar
• TianXQNiXWXuHLPrevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destructionInt J Nanomedicine2017127103711929026304
   PubMed Web of Science ®Google Scholar
• PistoneAIannazzoDAnsariSTunable doxorubicin release from polymer-gated multiwalled carbon nanotubesInt J Pharm20165151–2303627720871
   PubMedGoogle Scholar
• MashatADengLAltawashiASougratRWangGCKhashabNMZippered release from polymer-gated carbon nanotubesJ Mater Chem201222231150311508
   Web of Science ®Google Scholar
• IannazzoDPistoneASalamòMGraphene quantum dots for cancer targeted drug deliveryInt J Pharm20175181–218519228057464
   PubMedGoogle Scholar
• YadavAKMishraPJainSMishraPMishraAKAgrawalGPPreparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicinJ Drug Target200816646447818604659
   PubMed Web of Science ®Google Scholar
• ChoiSJChoyJHLayered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicityNanomedicine (Lond)20116580381421793673
   PubMed Web of Science ®Google Scholar
• LuoCSunJSunBFacile fabrication of tumor redox-sensitive nanoassemblies of small-molecule oleate prodrug as potent chemotherapeutic nanomedicineSmall201612466353636227689847
   PubMed Web of Science ®Google Scholar
• YuCTZhouMJZhangXJWeiWJChenXFZhangXHSmart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosisNanoscale20157135683569025740312
   PubMed Web of Science ®Google Scholar
• VendittoVJSzokaFCJrCancer nanomedicines: so many papers and so few drugs!Adv Drug Deliver Rev20136518088
   PubMed Web of Science ®Google Scholar
• HoffmanASStimuli-responsive polymers: biomedical applications and challenges for clinical translationAdv Drug Deliv Rev2013651101623246762
   PubMed Web of Science ®Google Scholar
• DawidczykCMKimCParkJHState-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesJ Control Release201418713314424874289
   PubMed Web of Science ®Google Scholar
• DanhierFTo exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine?J Control Release2016244Pt A10812127871992
   PubMed Web of Science ®Google Scholar
• MouQMaYZhuXYanDA small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapyJ Control Release2016230344427040815
   PubMed Web of Science ®Google Scholar
• ZhangTHuangPShiLLSelf-assembled nanoparticles of amphiphilic twin drug from floxuridine and bendamustine for cancer therapyMol Pharm20151272328233625996874
   PubMedGoogle Scholar
• HuangPWangDLSuYCombination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapyJ Am Chem Soc201413633117481175625078892
   PubMed Web of Science ®Google Scholar
• CheethamAGZhangPCLinYALockLLCuiHGSupramolecular nanostructures formed by anticancer drug assemblyJ Am Chem Soc201313582907291023379791
   PubMed Web of Science ®Google Scholar
• JiangYWangXLiuXEnhanced antiglioma efficacy of ultrahigh loading capacity paclitaxel prodrug conjugate self-assembled targeted nanoparticlesACS Appl Mater Interfaces20179121121727976583
   PubMed Web of Science ®Google Scholar
• StacpoolePWKerrDSBarnesCControlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in childrenPediatrics200611751519153116651305
   PubMed Web of Science ®Google Scholar
• BonnetSArcherSLAllalunis-TurnerJA mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growthCancer Cell2007111375117222789
   PubMed Web of Science ®Google Scholar
• SuLZhangHYanCSuperior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor modelOncotarget2016740657216573127582548
   PubMedGoogle Scholar
• WongKEMoraMCSkinnerMEvaluation of polyMPC-Dox prodrugs in a human ovarian tumor modelMol Pharm20161351679168727023764
   PubMedGoogle Scholar
• MaksimenkoADosioFMouginJA unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activityProc Natl Acad Sci U S A20141112E217E22624385587
   PubMed Web of Science ®Google Scholar
• YuanAWuJHSongCCA novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicityJ Pharm Sci201310251626163523423631
   PubMed Web of Science ®Google Scholar